JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 2, 2006; DOI: 10.1124/jpet.106.115212


0022-3565/07/3202-544-551$20.00
JPET 320:544-551, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.115212v1
320/2/544    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, Z.-G.
Right arrow Articles by Yang, Y.-Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, Z.-G.
Right arrow Articles by Yang, Y.-Q.

CARDIOVASCULAR

Dihydropyridines Inhibit Acetylcholine-Induced Hyperpolarization in Cochlear Artery via Blockade of Intermediate-Conductance Calcium-Activated Potassium Channels

Zhi-Gen Jiang, Xiao-Rui Shi, Bing-Cai Guan, Hui Zhao, and Yu-Qin Yang

Oregon Hearing Research Center, Oregon Health and Science University, Portland, Oregon (Z.-G.J., X.-R.S., B.-C.G., H.Z., Y.-Q.Y.); and Department of Otolaryngology, Eye Ear Nose and Throat Hospital, Fudan University, Shanghai, People's Republic of China (H.Z.)

Acetylcholine (ACh) induces hyperpolarization and dilation in a variety of blood vessels, including the cochlear spiral modiolar artery (SMA) via the endothelium-derived hyperpolarization factor (EDHF). We demonstrated previously that the ACh-induced hyperpolarization in the SMA originated in the endothelial cells (ECs) by activating a Ca2+-activated K+ channel (KCa); the hyperpolarization in smooth muscle cells was mainly an electrotonic spread via gap junction coupling. In the present study, using intracellular recording, immunohistology, and vascular diameter tracking techniques on in vitro SMA preparations, we found that 1) ACh-induced hyperpolarization was suppressed by intermediate-conductance KCa (IK) blockers clotrimazole (IC50 = 116 nM) and nitrendipine and by the calmodulin antagonist trifluoperazine, but it was not suppressed by the big-conductance KCa blocker iberiotoxin. The immunoreactivity to anti-SK4/IK1 antibody was localized mainly in ECs. 2) The three dihydropyridines—nifedipine, nitrendipine, and nimodipine—all concentration-dependently inhibited the ACh-induced hyperpolarization, with an IC50 value of 455, 34, and 3.2 nM, respectively. 3) Among other L-type Ca2+ channel (IL) blockers, 10 µM verapamil exerted a 20% inhibition on ACh-induced hyperpolarization, whereas diltiazem and the metal ion Ca2+ channel blockers Cd2+ and Ni2+ had no effect. 4) Nitrendipine and charybdotoxin abolished ACh-induced dilation in the SMA. We conclude that ACh-induced hyperpolarization in the SMA is generated mainly by activation of the IK in the ECs, and dihydropyridines suppress the EDHF-mediated hyperpolarization by blocking the IK channel, not the IL channel. The clinical relevance of this dihydropyridine action is discussed.


Received October 8, 2006; accepted October 31, 2006.

Address correspondence to: Dr. Zhi-Gen Jiang, Oregon Hearing Research Center, NRC04, Oregon Health and Science University, Portland, OR 97239. E-mail: jiangz{at}ohsu.edu




This article has been cited by other articles:


Home page
Circ. Res.Home page
K. A. Dora, N. T. Gallagher, A. McNeish, and C. J. Garland
Modulation of Endothelial Cell KCa3.1 Channels During Endothelium-Derived Hyperpolarizing Factor Signaling in Mesenteric Resistance Arteries
Circ. Res., May 23, 2008; 102(10): 1247 - 1255.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. D. Dietz, S. Du, C. W. Bolten, M. A. Payne, C. Xia, J. R. Blinn, J. W. Funder, and X. Hu
A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity
Hypertension, March 1, 2008; 51(3): 742 - 748.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.